| |
Other Press releases  |
|
| |
Mark Kaufmann, Allostera Pharma, winner of the Brio Award
...Mark Kaufmann, Allostera Pharma, winner of the Brio Award |
|
| |
| |
Dr. Samir Mounir Appointed Director of Laval's Biotech City and BIOPOLE
...Dr. Samir Mounir Appointed Director of Laval's Biotech City and BIOPOLE |
|
| |
| |
October 23, 2009-Angiochem's ANG1005 demonstrates safety and efficacy in Phase 1/2 brain cancer studies
...and efficacy in Phase 1/2 brain cancer studies |
|
| |
| |
Oct, 23. 2009. MNA Guy Ouellette announces $495,000 in funding for the Québec Biotechnology Innovation CentrePage title (default)
... for the Québec Biotechnology Innovation Centre |
|
| |
| |
September 9th 2009 - CED awards $850K to Bio-K Plus Intl.
...for implementation of U.S.-oriented marketing strategy. |
|
| |
| |
August 18th 2009 - Osta Biotechnologies - Grant Awarded
Prostate Cancer Canada Grants Award to Osta's Principal Investigator |
|
| |
| |
July 27th 2009 - BioFocus DPI and Oncodesign forge alliance to provide integrated oncology drug discovery services.
...to provide integrated oncology drug discovery services. |
|
| |
| |
July 9th 2009 - AngioChem - First U.S. Patent
AngioChem Granted First U.S. Patent Covering Angiopep-2 |
|
| |
| |
June 19th 2009 - QBIC receives 1,1 M$ in funding from the Government of Canada
|
|
| |
| |
April 20th 2009 - Technologie BiolActis - positive results from its phase II trials
|
|
| |
| |
April 3rd 2009 - Nomination of Dr. Gagné at Montreal InVivo's Board of Directors
|
|
| |
| |
May 20th 2009 - Warnex Completes its Debt Restructuring
|
|
| |
| |
May 6th 2008 - Warnex Announces Agreement with Desjardins Group
|
|
| |
| |
April 30th 2008 - Warnex Appoints Two New Directors ...
"It is with great pleasure that we welcome these two new members to Warnex's Board of Directors". |
|
| |
| |
April 3rd 2008 - Adaltis Appoints Chief Operating Officer for China
''The Company's plan is to continuously leverage the investments in our China-based operations ...'' |
|
| |
| |
March 27th 2008 - Adaltis Announces $ 14,9 Million Rights Offering ...
Signs Stand-by Purchase Agreement with Key Strategic Shareholders ... |
|
| |
| |
Warnex Reports Fourth Quarter and Year End ...
2007 Highlights, Financial Results, etc. |
|
| |
| |
Adaltis Announces Agreement to Sell ...
Continued Focus on China and Emerging markets |
|
| |
| |
Warnex Offers New Prostate Cancer Screening Service
''we are pleased to offer this new prostate cancer screening assay, which ...'' |
|
| |
| |
Warnex Enters Into a New Lease
The new lease was entered into following the purchase of ... |
|
| |
| |
New Collaborative Agreement for Aurelium
... allowing Inverness to use five (5) of Aurelium's proprietary cancer biomarkers ... |
|
| |
| |
Technologie Biolactis announces the filing of a new patent ...
... of a new patent application protecting the recent discovery of ... |
|
| |
| |
Adaltis Signs Short Term Credit Facility
The facility is for an amount of up to ... |
|
| |
| |
Warnex Announces Results of Review of Strategic Options
2007 has been a year of many ... |
|
| |
| |
... shows Bio-K+CL1285(R) can prevent ...
Canadian independant medical study ... |
|
| |
| |
Adaltis Announces 2007 Third Quarter Financial Results
Financial Highlights for the Third Quarter |
|
| |
| |
Warnex Reports Third Quarter 2007 Results
Record Third Quarter Revenue and Positive EBITDA |
|
| |
| |
Adaltis Signs Important Cooperation Agreement with ...
Adaltis ... is pleased to announce the execution of ... |
|
| |
| |
QBIC Connects with China by Signing a Framework Partnership Agreement
QBIC today signed a framework agreement with ... |
|
| |
| |
AngioChem announces IND clearance from the US FDA ...
AngioChem is pleased to announce that it has received clearance ... |
|
| |
| |
Osta Biotechnologies Announces Breakthrough Results ...
Osta Biotechnologies today announced breakthrough results ... |
|
| |
| |
Biolactis welcomes Mr. Marc Lalonde ...
Technologie Biolactis, inc., a Canadian biotechnology company specializing in ... |
|
| |
| |
Warnex to Provide Bioavailable Testosterone Testing ...
Warnex inc. today announced that its Medical Laboratories division has signed ... |
|
| |
| |
Adaltis HIV Ag/Ab Diagnostic Test is ranked ...
Adaltis inc., an international in vitro diagnostic company ... |
|
| |
| |
Technologie Biolactis 2007 Recipient Promising Early Stage Company
BIOTECanada and MEDEC are proud to be associated for ... |
|
| |
| |
QBIC and its Resident Companies Present at BIO 2007
BIO, the largest conference-exposition in biotechnology in the world ... |
|
| |
| |
Innodia inc. Appoints Two New Members to its Scientific Advisory Board
Innodia inc. is pleased to announce the appointments of ... |
|
| |
| |
Innodia initiates a phase II clinical trial with Adyvia
Innodia inc. announced the initiation of a Phase IIa clinical trial ... |
|
| |
| |
Innodia inc. appoints Dr. Nigel Levens as Chief Scientific Officer
Innodia inc. is pleased to announce the appointment of ... |
|
| |
| |
Innodia receives 2006 Genesis Award for innovation
Innodia inc. announced today that it has received the Genesis 2006 Award for ... |
|
| |
| |
Innodia named a Red Herring 100 Winner
Innodia inc. announced today that it has been selected as a winner of the ... |
|
| |
| |
Technologie Biolactis arrives at QBIC
Technologie Biolactis inc., specializing in the development of lactoceuticals ... |
|
| |
| |
REPLICor's Antiviral Drug is active against H5N1 Avian Flu
REPLICor's lead compound, REP 9, has been shown to have potent... |
|
| |
| |
Innodia closes $10M convertible debenture financing
Innodia inc. is pleased to announce ... |
|
| |
| |
Innodia is selected as one of Canada's ...
Innodia is selected as one of Canada's top 10 life science companies |
|
| |
| |
REPLICor's antiviral drug - November 1st, 2005
Potent Activity against H5N1 Avian Flu ... |
|
| |
| |
Prix de l'émergence from the Armand-Frappier Foundation - June 15, 2005
June 15, 2005 - Innodia is honored with prestigious Prix de l'émergence from the Armand-Frappier Foundation |
|
| |
| |
The CQIB celebrates its 10th anniversary / ceremony - May 13, 2005
The Quebec Biotechnology Innovation Centre (QBIC), a specialized biotech business incubator, today celebrated its 10th anniversary before more than 100 guests in Laval... |
|
| |
| |
Government of Canada renews 1.2 M partnership agreement with the QBIC - May 13, 2005
Government of Canada renews 1.2 M partnership... |
|
| |
| |
QBIC Celebrates It's 10th Anniversary - Biomedex - March 31, 2005
Over 300 guests, partners and professionals from the Canadian biotech industry were invited... |
|
| |
| |
QBIC Inaugurates Its New Facilities in Laval - October 20, 2003
|
|
| |
 |
|
 |
 |
 |
